FAQ Gummies

  • What is the difference between full-spectrum and isolate CBD gummies?

    Half Day offers two categories of CBD gummies: Isolate and Full-Spectrum, both of which we make in-house, from scratch, in small batches. Our isolate gummies contain only CBD and 0% THC; our full-spectrum CBD gummies, however, contain several cannabinoids, including CBD, CBN, CBC, CBG and, yes, small amounts of THC (about 1mg per 25mg gummy). Research suggests CBD users will gain the most benefit from full-spectrum products (thanks to the "Entourage Effect"); however, if you are extra sensitive to or need to avoid THC, we recommend our isolate gummies.

  • Are CBD gummies legal?

    The Farm Bill was signed into law in December 2018, and it legalized CBD derived from hemp, as long as it contains no more than 0.3% THC. Half Day CBD gummies are made from legal, hemp-derived CBD: American-grown, all-natural hemp, free from pesticides, herbicides, solvents, or chemical fertilizers. Our products are all regulatory compliant, containing less than 0.3% THC. Every batch is third-party lab-tested to ensure safety and potency.

  • Are CBD gummies addictive?

    Rest assured, CBD gummies are not addictive, but for those with a sweet tooth, we can't promise they won't be tempting!

  • Can pregnant women still take CBD products?

    Unfortunately, there isn't a definitive answer regarding the safety of taking CBD while pregnant. That's because we've only scratched the surface when it comes to CBD research, which means that we still don't have as many studies on the topic as we would like. As this industry continues to expand and grow, we hope to see some educational research on the subject. Until then, we can't say for certain.

    If you are a pregnant woman who wishes to take CBD or maintain an already-existing CBD routine, the first thing that you should do is speak with your doctor.

  • Has CBD oil gotten FDA approval yet?

    Meeting FDA approval requires time and money. CBD derived from hemp is a relatively new product on the market. In essence, it hasn’t had the time and investment yet to conduct extensive studies for submission to the FDA and possible approval.

    The good news is, there hasn't been any evidence to suggest that CBD in and of itself is unsafe. Basically, the FDA doesn't know yet if CBD will interact with other products, and if those interactions might be harmful to consumers. As the CBD market continues to evolve and has time to grow, the FDA will eventually have the information it needs to approve CBD for official use.